ARH Regional Medical Center

Hazard, Kentucky

Use our guide to learn which trials are right for you!

We've found
1 trials
at this facility
Carcinoma, Non-Small-Cell Lung Clinical Trial
A Study of Tislelizumab (BGB-A317) Plus Chemoradiotherapy Followed by Tislelizumab Monotherapy in Newly Diagnosed, Stage III Subjects With Locally Advanced, Unresectable Non-small Cell Lung Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
ARH Regional Medical Center
mi
from
Hazard, KY
Click here to add this to my saved trials